Title |
CellML: its future, present and past
|
---|---|
Published in |
Progress in Biophysics & Molecular Biology, June 2004
|
DOI | 10.1016/j.pbiomolbio.2004.01.004 |
Pubmed ID | |
Authors |
Catherine M. Lloyd, Matt D.B. Halstead, Poul F. Nielsen |
Abstract |
Advances in biotechnology and experimental techniques have lead to the elucidation of vast amounts of biological data. Mathematical models provide a method of analysing this data; however, there are two issues that need to be addressed: (1) the need for standards for defining cell models so they can, for example, be exchanged across the World Wide Web, and also read into simulation software in a consistent format and (2) eliminating the errors which arise with the current method of model publication. CellML has evolved to meet these needs of the modelling community. CellML is a free, open-source, eXtensible markup language based standard for defining mathematical models of cellular function. In this paper we summarise the structure of CellML, its current applications (including biological pathway and electrophysiological models), and its future development--in particular, the development of toolsets and the integration of ontologies. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 8 | 4% |
United Kingdom | 6 | 3% |
France | 3 | 2% |
Italy | 3 | 2% |
New Zealand | 3 | 2% |
Brazil | 2 | 1% |
Canada | 2 | 1% |
Australia | 1 | <1% |
Sweden | 1 | <1% |
Other | 4 | 2% |
Unknown | 157 | 83% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 57 | 30% |
Student > Ph. D. Student | 51 | 27% |
Student > Master | 14 | 7% |
Professor | 11 | 6% |
Student > Doctoral Student | 10 | 5% |
Other | 33 | 17% |
Unknown | 14 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 63 | 33% |
Computer Science | 41 | 22% |
Engineering | 24 | 13% |
Biochemistry, Genetics and Molecular Biology | 14 | 7% |
Medicine and Dentistry | 9 | 5% |
Other | 17 | 9% |
Unknown | 22 | 12% |